Farahdina Farahdina

Farahdina Farahdina

Auto-generated profile, based on publicly available information

Farahdina Farahdina

Department of Child Health, Faculty of Medicine, Universitas Airlangga - Dr. Soetomo General Academic Hospital, Surabaya, Indonesia

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2023 in Open Access Macedonian Journal of Medical Sciences
Verified
Journal Article
Open access
PDF file
NRNur Rochmah
Nur Rochmah
FFFarahdina Farahdina
Farahdina Farahdina
WDWika Yuli Deakandi
Wika Yuli Deakandi
QPQurrota Ayuni Novia Putri
Qurrota Ayuni Novia Putri
TNTyas Maslakhatien Nuzula
Tyas Maslakhatien Nuzula
MFMuhammad Faizi
Muhammad Faizi
BACKGROUND: The COVID-19 pandemic determined a profound impact on the routine follow-up of type 1 diabetes (T1D) children. Telemedicine represents a critical tool to guarantee regular care for these patients in this form. AIM: The purpose of this study was to assess the impact of telemedicine programs during the COVID-19 pandemic era on T1D children. PATIENTS AND METHODS: Studies from PubMed, Cochrane, and Directory of Open Access Journals from December 2021, to February 18, 2022, were conducted to calculate the pooled mean difference using either a random or fixed-effect model in Review Manager version 5.3. Our study has applied to ensure that our procedures, including record collection, extraction of data, quality evaluation, and statistical analysis, adhere to the Preferred Reporting Items for Systematic Examination and Meta-Analysis guidelines. RESULTS: Three articles relevant to the current study (436 children). Our pooled analysis found that there was an impact of telemedicine in reducing the HbA1c (mean diff: 5.64 [95% confidence interval (CI) 3.71–7.57], p < 0.00001). However, the physical activity was not affected by the telemedicine program (mean diff: −37.25 [95% CI −317.53–243.02], p = 0.79). CONCLUSION: Our findings suggest that telemedicine has a role in T1D children controlling HbA1c during the COVID-19 pandemic. Meanwhile, telehealth has emerged as a promising alternate mode of health-care delivery. Its utility during the pandemic warrants further investigation.

1 July 2024 in Biomolecular and Health Science Journal
Verified
Journal Article
Open access
FFFarahdina Farahdina
Farahdina Farahdina
RPRendi Aji Prihaningtyas
Rendi Aji Prihaningtyas
BSBagus Setyoboedi
Bagus Setyoboedi
ASAgnescia Clarissa Sera
Agnescia Clarissa Sera
SASjamsul Arief
Sjamsul Arief
Introduction: Biliary atresia (BA) is a rare and devastating pediatric liver disorder characterized by progressive obstruction or absence of the extrahepatic bile ducts within infants. One crucial aspect of understanding the disease process is the assessment of liver fibrosis. The De Ritis ratio can serve as an early screening tool for clinicians that assists in identifying patients at risk of progressive fibrosis. Combining this ratio with other noninvasive markers and imaging techniques may further enhance its accuracy in assessing the severity of fibrosis. Our study aims to investigate the utility of the De Ritis (aspartate aminotransferase (AST)/alanine aminotransferase (ALT) ratio and serum albumin levels as noninvasive markers of liver fibrosis in BA. Methods: This research was a cross-sectional study utilizing medical record data of pediatric patients with BA from November 1, 2022, to November 30, 2023. Sex, age, presence of malnutrition, and blood parameters including hemoglobin, leucocytes, and platelets (Plts) were collected. AST/ALT ratio and other laboratory parameters’ correlations were analyzed using Spearman’s correlation. Results: There was a positive correlation between the De Ritis ratio and Plts ( P < 0.001, r = 1.000), activated partial thromboplastin time ( P < 0.001, r = 1.000), partial thromboplastin time ( P < 0.001, r = 0.999), and albumin ( P < 0.001, r = 1.000). Conclusion: The De Ritis ratio and albumin levels have association with liver fibrosis formation might suggesting their potential use as predictive markers for disease progression in children with BA optimizing the patient’s nutritional well-being.

28 October 2024 in Heart Science Journal
Verified
Journal Article
Closed access
JAJustika Usmadhani Aulya
Justika Usmadhani Aulya
AMAsri Rizqi Matondang
Asri Rizqi Matondang
FFFarahdina Farahdina
Farahdina Farahdina
FRFerdian Rizaliansyah
Ferdian Rizaliansyah
NSNur Samsu
Nur Samsu
JFJonny Karunia Fajar
Jonny Karunia Fajar
Background: In Indonesia, wet cupping therapy has been thoroughly investigated as a treatment for hypertension and dyslipidemia. Nevertheless, the outcomes across these studies are contradictory. Objectives: To appraise the effectiveness of wet cupping therapy in the management of hypertension and dyslipidemia among the Indonesian population. Methods: We examined papers sourced from Google Scholar, the Indonesian Scientific Journal Database, and Garba Rujukan Digital until September 5, 2020. These papers investigated blood pressure and lipid profile levels both pre- and post-wet cupping treatment. The collective data underwent Z-test analysis to assess associations. Results: In total, we included 26 papers examining the correlation between wet cupping therapy and blood pressure, as well as 16 papers assessing lipid profile levels. Our combined analysis revealed significantly reduced systolic blood pressure (MD: 13.86; 95% CI: 10.01, 17.71), diastolic blood pressure (MD: 6.31; 95% CI: 3.84, 8.79), and lower total cholesterol levels (MD: 21.56; 95% CI: 10.32, 32.80]) in the post-treatment group compared to the pre-treatment group. However, we were unable to elucidate the impact of wet cupping therapy on the concentrations of low-density lipoprotein and triglyceride. Conclusions: Wet cupping therapy exhibits potential efficacy in reducing blood pressure and total cholesterol levels among individuals in Indonesia. Keyword: blood pressure, dyslipidemia, hypertension, lipid profile, wet cupping therapy